Table 1.
Groups | Initial body weight (g) | Final body weight (g) | Variation weight (g) | LSI (%) |
---|---|---|---|---|
G1 | 271.43 ± 20.56a | 210.05 ± 10.13a | −61.38 ± 16.41a | 5.97 ± 0.42a |
G2 | 259.29 ± 10.97a | 211.14 ± 8.59a | −48.15 ± 15.36a | 5.85 ± 0.51a |
G3 | 263.58 ± 20.35a | 247.43 ± 16.47b | −16.15 ± 13.09b | 4.10 ± 0.49b |
G4 | 256.71 ± 13.67a | 215.00 ± 8.01a | −41.71 ± 10.17a | 5.71 ± 0.43a |
G5 | 268.57 ± 14.06a | 212.14 ± 23.07a | −56.42 ± 12.10a | 4.41 ± 0.53b |
G6 | 261.45 ± 13.49a | 250.33 ± 11.52b | −11.12 ± 8.73b | 4.18 ± 0.50b |
LSI, liver somatic index. Liver injury was induced by intraperitoneal administration of CCl4 (60% v/v, 1 ml/kg) every 48 h for 12 days. Group 1 (G1): CCl4; Group 2 (G2): dimethyl sulfoxide (DMSO) + CCl4; Group 3 (G3): BCE (400 mg/kg); Group 4 (G4): BCE 200 + CCl4; Group 5 (G5): BCE 400 + CCl4; Group 6 (G6): DMSO. (−) Negative sign indicates weight loss. Data are expressed as mean ± SD. Different letters in the columns indicate statistical difference between groups (P < 0.05), and groups with the same letter do not differ statistically, one-way anova.